person · Reporting owner
Armstrong Linda Washington
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| iBio, Inc.IBIO · Entity 6906 | Director | December 09, 2021 | December 14, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
iBio, Inc.
Report date December 09, 2021 · Filed December 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.69 · Expires 2031-12-08 | Direct | 109,000 |
Reported balance
After 2021-12-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-12-09 · Grant · Acquired 109,000 · Balance 109,000 F1: These options vest pro rata on a monthly basis over 12 months. |
Filing footnotes · ownership attribution and instrument terms
F1: These options vest pro rata on a monthly basis over 12 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2021 Filed Dec 14, 2021 00:06 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 109,000 | $0.00 Strike: $0.69 | $0.00 |
DisclosureSEC source: 0001104659-21-149231 · tm2135158-7_4seq1.xml · derivative · entry 1 Armstrong Linda Washington · CIK 0001825579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,000 Underlying: Common Stock · 109,000 shares Expires 2031-12-08 F1 · security: These options vest pro rata on a monthly basis over 12 months. F1 · shares: These options vest pro rata on a monthly basis over 12 months. F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over 12 months. Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 10:10 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001104659-20-115459 · tm2033244d6_form4.xml · derivative · entry 1 Armstrong Linda Washington · CIK 0001825579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-10-13 F1 · shares: These options vest pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over 36 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.